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Encephalitis is a major cause of death worldwide. Al-
though >100 pathogens have been identifi ed as causative 
agents, the pathogen is not determined for up to 75% of 
cases. This diagnostic failure impedes effective treatment 
and underscores the need for better tools and new ap-
proaches for detecting novel pathogens or determining new 
manifestations of known pathogens. Although astroviruses 
are commonly associated with gastroenteritis, they have 
not been associated with central nervous system disease. 
Using unbiased pyrosequencing, we detected an astrovirus 
as the causative agent for encephalitis in a 15-year-old boy 
with agammaglobulinemia; several laboratories had failed 
to identify the agent. Our fi ndings expand the spectrum of 
causative agents associated with encephalitis and highlight 
unbiased molecular technology as a valuable tool for differ-
ential diagnosis of unexplained disease.
The economic cost of encephalitis is profound.  Among the general population of western industrialized coun-
tries, the annual incidence of acute encephalitis is 7.3 cases 
per 100,000 persons (1). Although some persons recover 
from encephalitis without apparent sequelae, up to 71.0% 
experience lasting sequelae and up to 7.4% die (1,2). Khet-
suriani et al. reported that each year in the United States 
alone, encephalitis is associated with ≈19,000 hospitaliza-
tions (average hospital stay 12 days), 1,400 deaths, and a 
cost of ≈$650 million for encephalitis-associated hospital-
ization (1).
Encephalitis is associated with a wide spectrum of in-
fectious agents, including viruses, bacteria, fungi, and para-
sites (3). The most commonly implicated viruses are herpes 
simplex, varicella-zoster, Epstein-Barr, mumps, measles, 
and enteroviruses (4). Despite the use of various diagnos-
tic methods (culture, molecular, immunohistochemical, or 
serologic), a causative agent is not identifi ed for a high pro-
portion of encephalitis cases (up to 75%) (5). This diagnos-
tic failure may refl ect the absence of a known agent or its 
molecular footprint at time of sampling, suboptimal speci-
men handling, lack of assay sensitivity, or presence of an 
unexpected or novel agent not considered in conventional 
assays. A better understanding of emerging and reemerg-
ing pathogens implicated in outbreaks of encephalitis (e.g., 
West Nile virus, Hendra virus, Nipah virus, Australian bat 
lyssavirus, and enterovirus 71) indicates an urgent need for 
novel tools for rapid differential diagnostic testing and sur-
veillance (6,7).
The advent of unbiased molecular discovery technolo-
gies offers new opportunities to identify novel pathogens 
without the constraints imposed by assays selective for 
known or expected agents. We used unbiased high-through-
put pyrosequencing to detect an astrovirus in a patient who 
died with unexplained encephalitis.
Materials and Methods
The Patient
In 2007, a 15-year-old boy with X-linked agammaglob-
ulinemia (XLA) caused by a missense mutation (Thr35Pro) 
in the Bruton tyrosine kinase (Btk) gene was admitted to a 
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psychiatric facility in Seattle, WA, USA, because of sui-
cidal and homicidal ideation, headache, memory loss, and 
ataxia. He had progressive cognitive decline, was unable to 
walk or communicate within 4 weeks of admission, became 
comatose, and died 71 days after admission.
Samples
Patient samples available for examination were fresh-
frozen biopsy specimens of frontal cortex and postmortem 
tissues (brain stem, frontal lobe, kidney, liver, and spleen). 
Also available for immunohistochemical and neuropatho-
logic examination were formalin-fi xed postmortem sam-
ples of cerebral cortex, basal ganglia, and cerebellum from 
the patient and from other persons without encephalitis or 
brain infl ammation.
Unbiased High-Throughput Sequencing
RNA (0.5 μg) from the frontal cortex biopsy speci-
men was treated with DNase I (Ambion DNA-free; Aus-
tin, TX, USA) and reverse transcribed by using Superscript 
II (Invitrogen, Carlsbad, CA, USA) with random octamer 
primers linked to an arbitrary defi ned 17-mer primer se-
quence (Eurofi ns MWG Operon, Huntsville, AL, USA). 
cDNA was treated with RNase H before random PCR am-
plifi cation with a 9:1 mixture of a 17-mer random sequence 
primer and an octamer-linked 17-mer random sequence 
primer (8). Products with >70 bp were purifi ed by using 
MinElute (QIAGEN, Valencia, CA, USA) and ligated 
to linkers for sequencing on a GSL FLX Sequencer (454 
Life Sciences, Branford, CT, USA). After primers were 
trimmed and highly repetitive sequences eliminated, reads 
were clustered and assembled into contiguous fragments 
for comparison by BLAST (9) with the GenBank database 
at the nucleotide and translated amino acid levels. We used 
custom software applications written in Perl (BioPerl 5.8.5) 
and programs available through the GreenePortal website 
(http://tako.cpmc.columbia.edu/Tools/).
Rapid Amplifi cation of cDNA Ends
Virus-specifi c primers for 5′ rapid amplifi cation of 
cDNA ends were 5′-ACGCTCAAGCTCATGTCT
GA-3′ for reverse transcription, 5′-GATGAGCGCTCTG
TTTTCAA-3′ for the fi rst PCR with UAP (Invitrogen), and 
5′-TCAACCTCAACCCAATCGTT-3′ for the second PCR 
with AUAP (Invitrogen). Primers for 3′ rapid amplifi cation 
of cDNA ends were 5′-CTCGCAAGGCATATGAGTGA-3′ 
and UAP (Invitrogen) for the fi rst PCR and 5′-
CTGGCTTGGTTGCAAAAGTT-3′ and AUAP (Invitro-
gen) for the second PCR. Final concentration of all prim-
ers was 0.2 mmol/L. PCR products were purifi ed with 
QIAquick PCR Purifi cation kits (QIAGEN) and directly 
dideoxy sequenced in both directions.
Quantitative Real-Time PCR
Reactions were performed in an ABI 7300 cy-
cler by using SYBR-Green Master Mix (Applied 
Biosystems, Foster City, CA, USA) with primers 5′-
CCATGTGTCTGATGGTGCTG-3′ and 5′-TTGATC
ATATCAATCACCAAATCA-3′ in a volume of 25 μL. 
Cycling conditions were 50°C for 2 min and 95°C for 10 
min, followed by 45 cycles at 95°C for 15 s and 60°C for 
1 min.
Cloning, Expression, and Purifi cation of VP29
The VP29 variable region of the capsid gene (nt 5231–
6562) was amplifi ed by PCR with forward VP29-KpnI 
primer 5′-CGGGGTACCTGCTAGGTAAATCAGCAA
ATACT-3′ and reverse VP29-XhoI primer 5′-CCGCTCG
AGTTGATCATATCAATCACCAAATCA-3′. Histidine 
6–tagged VP29 was expressed in Escherichia coli (Gate-
way vector pDEST 17; Invitrogen) and purifi ed by using 1 
mL Histrap column (GE Healthcare Life Sciences, Piscat-
away, NJ, USA) in denaturing binding buffer (20 mmol/L 
Tris-HCl [pH 8], 6 M guanidine, 0.5 M NaCl, 20 mmol/L 
imidazole), washed with 5 column volumes of denaturing 
binding buffer followed by 5 column volumes of denatur-
ing wash buffer (20 mmol/L Tris-HCl  [pH 8], 6 M urea, 
0.5 M NaCl, 20 mmol/L imidazole), and eluted in dena-
turing elution buffer (20 mmol/L Tris-HCl [pH 8], 6 M 
urea, 0.5 M NaCl, 0.5 M imidazole). Peak fractions were 
analyzed by sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis, pooled, and dialyzed against 20 mmol/L 
Tris-HCl (pH 8) and 3 M urea. Purifi cation of VP29 was 
confi rmed by Western blot with anti-histidine antibody 
(Genscript, Piscataway, NJ, USA) and mass spectroscopy 
of a trypsin-digested purifi ed sample.
Rabbit antiserum against VP29 was generated by in-
jecting rabbits with recombinant VP29 (3 injections of 
0.5 mg each in Freund complete/incomplete adjuvant). 
Immunoglobulin (Ig) G was purifi ed by using protein A-
Sepharose (Lampire Biologic Laboratories, Pipersville, 
PA, USA).
Immunohistochemistry and Immunofl uorescence
Formalin-fi xed, paraffi n-embedded brain sections 
were heated at 56°C for 10 min, deparaffi nized in a citrus 
clearing agent, and rehydrated through decreasing concen-
trations of ethanol. Endogenous peroxidase activity was 
blocked with 3% hydrogen peroxide for 15 min. Heat-in-
duced antigen retrieval was performed in Trilogy antigen 
retrieval solution (Cell Marque, Rocklin, CA, USA) for 
20 min at 95°C, after which the solution was cooled for 
30 min. After blocking with Background Sniper solution 
(BS966H; Biocare Medical, Concord, CA, USA) for 10 
min at room temperature, sections were incubated with pri-
mary antibodies overnight at 4°C. Slides were washed with 
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wash buffer (Dako, Carpinteria, CA, USA) and incubated 
with appropriate secondary antibody for either immunohis-
tochemical or immunofl uorescence examination.
For immunohistochemical examination, Vectastain 
Elite ABC kits (PK-6101, AK5002; Vector Laboratories, 
Burlingame, CA, USA) were used to develop diaminoben-
zidine tetrahydrochloride chromogen. Tissue sections were 
incubated with either biotinylated goat antirabbit or bioti-
nylated horse antimouse IgG (1:200, Vector Laboratories) 
for 1 h at 37°C, after which ABC reagents were added. Sec-
tions were counterstained with hematoxylin and dehydrated 
with 100% ethanol. Sections were affi xed to slides by using 
Permount histologic mounting medium (Fisher, Fair Lawn, 
NJ, USA), and coverslips were placed.
For immunofl uorescence assays, sections were incu-
bated with secondary Cy3-conjugated goat antirabbit anti-
body or Cy2 goat antimouse antibody (1:200, Jackson Im-
munoResearch Laboratories, West Grove, PA, USA) for 1 
h at room temperature. Sections were mounted on slides by 
using ProLong Gold antifade reagent with DAPI (Invitro-
gen). Images were viewed on a Zeiss LSM 510 multiphoton 
confocal microscope and analyzed by using AIM Software 
(Carl Zeiss GmbH, Thornwood, NY, USA). Primary anti-
bodies used were mouse antiglial fi brillary acidic protein 
cocktail (1:100, BD Bioscience Pharmagen, San Jose, CA, 
USA), mouse anti-CD3 (1:350, Dako), and mouse anti-
CD68 (1:50, Dako).
Phylogenetic Analysis
Representative capsid gene (open reading frame 2) 
sequences were downloaded from GenBank, and aligned 
with the capsid gene sequence of the novel astrovirus by 
using Se-Al version 2.0a11 (http://tree.bio.ed.ac.uk/soft-
ware/seal/). A Bayesian phylogenetic tree based on the 
full-length amino acid alignment of the capsid protein 
was generated by using MrBayes version 3 (10) and the 
WAG amino acid transition model. Two independent runs 
were allowed to converge over 10 million generations, 
burn-in setting was 10%, and every 1,000 generations 
were sampled. The robustness of the resultant phyloge-
netic analysis was assessed by using Bayesian posterior 
probability values.
Results
During the patient’s hospitalization, Gram stain, bac-
terial cultures, PCR, and cryptococcal antigen tests of 
2 cerebrospinal fl uid samples performed on days 6 and 
12 after hospitalization failed to detect any agents that 
might be implicated in disease (Tables 1–4). Examination 
of a frontal cortex biopsy found diffuse astrogliosis and 
microgliosis of gray and white matter, perivascular and 
parenchymal CD3+ T-cell infi ltrates, neuronal loss, and 
axonal swelling. No Negri bodies, Cowdry inclusions, 
or evidence of prion disease were found. No infectious 
agents were detected by electron microscopy or immu-
nohistochemistry when a panel of antiserum for detection 
of herpes simplex virus, polyomavirus, and adenovirus 
was used. Bacterial and fungal cultures, broad-based 16S 
rRNA PCR, viral culture, and PCR for multiple viruses 
were negative (Tables 2–4).
Histologic examination of postmortem brain speci-
mens showed diffuse neuronal loss, cortical thinning, and 
vacuolation of the gray matter of the cortices and deep nu-
clei (Figure 1, panels A, B) accompanied by astrogliosis 
in cortex and subcortical white matter (Figure 1, panels C, 
D). CD3+ T-lymphocytes were identifi ed in the perivascu-
lar spaces, infi ltrating the parenchyma (Figure 1, panel E), 
and in microglial nodules (Figure 1, panel F). No CD20+ 
B cells were noted. The white matter showed vacuolation 
and myelin clumps consistent with myelin degeneration 
(Figure 1, panel G), axonal loss (Figure 1, panel H), and 
microgliosis (Figure 1, panel I). Microcalcifi cations were 
seen in the globus pallidus (Figure 1, panel J).
Because the histologic fi ndings were consistent with 
virus infection and because molecular, serologic, and 
morphologic methods failed to identify an infectious 
agent, we pursued unbiased pyrosequencing of RNA from 
the frontal cortex biopsy specimen (11,12). From 2 cDNA 
libraries that mapped either to human (host) sequences or 
were uninformative in GenBank searches at the nucleotide 
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(ref 45%–60% of 
glucose in serum) 
Immunoglobulin G, 
mg/dL (ref 0.8–7.7) 
6 4 2 2 76 50 ND 
12 6 107 1 48 57 3.7
*Ref, reference range; ND, not done. 
Table 2. Staining and culture results for 15-year-old boy with X-linked agammaglobulinemia and  astrovirus encephalitis* 
Sample AFB stain Gram stain Cryptococcal antigen Bacterial culture† Fungal culture Viral culture 
Cerebrospinal fluid ND Neg Neg Neg ND ND 
Brain biopsy Neg ND ND Neg Neg Neg 
*AFB, acid-fast bacteria; ND, not done; neg, negative.  
†Includes Mycobacteria spp. 
Astrovirus Encephalitis
level (BLASTn), we obtained an average of 102,000 se-
quence fragments with a mean length of 180 nt. However, 
analysis at the deduced amino acid level (BLASTx) iden-
tifi ed 12 sequences homologous to astroviruses (Figure 2; 
Table 5). The complete 6,584-nt genomic sequence of the 
virus (GenBank accession no. GQ89199) was determined 
in a 2-step procedure in which gaps between sequence 
fragments identifi ed through pyrosequencing were fi lled 
by PCR amplifi cation and sequencing, and the genomic 
termini were cloned and sequenced by rapid amplifi cation 
of cDNA ends (Figure 2; Table 6). Phylogenetic analy-
ses placed the virus, tentatively named human astrovirus 
Puget Sound (HAstV-PS), apart from known human as-
troviruses. Analysis of the full-length capsid protein se-
quence showed HAstV-PS in a clade together with ovine, 
mink, and bat astroviruses (Figure 3); analyses of poly-
merase or protease protein sequences gave comparable 
results (data not shown).
Real-time PCR indicated that viral load was higher in 
the biopsy specimen (1.53 × 107 RNA molecules per reac-
tion) than in postmortem specimens (cerebellum [5.39 × 
102], frontal lobe [1.14 × 102], and brain stem [1.92 × 104]). 
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gondii Adenovirus BK virus CMV
Epstein-Barr





ND ND ND ND Neg Neg Neg Neg ND 
Brain Neg Neg Neg Neg Neg Neg Neg Neg Neg 
*CMV, cytomegalovirus; ND, not done; neg, negative. 
Table 4. PCR results for RNA viruses in 15-year-old boy with X-linked agammaglobulinemia and  astrovirus encephalitis* 
Sample Coronavirus Enterovirus HMPV HPIV 1 to 4 HSV 1 or 2 
Influenza
virus† Rhinovirus RSV VZV WNV
Cerebrospinal 
fluid
ND Neg Neg ND Neg ND ND ND Neg ND 
Brain  Neg Neg Neg Neg Neg Neg Neg Neg Neg Neg 
*HMPV, human metapneumovirus; HPIV, human parainfluenza virus; HSV, herpes simplex virus; RSV, respiratory syncytial virus; VZV, varicella zoster 
virus; WNV, West Nile virus; ND, not done; neg, negative. 
†Type A or B. 
Figure 1. Histologic fi ndings from brain of 15-year-old boy with X-linked agammaglobulinemia and astrovirus encephalitis. A) Frontal 
cortex with cortical thinning (double-headed arrow) and vacuolation (arrows) (Luxol fast blue stain with periodic acid–Schiff method [LFB/
PAS], original magnifi cation ×10). B) Frontal cortex with vacuolation (arrow) and rare residual neurons (arrowheads) (LFB/PAS, original 
magnifi cation ×50). C) Marked astrogliosis in the frontal cortex (glial fi brillary acidic protein [GFAP] immunostain, original magnifi cation 
×100). D) White matter with marked astrogliosis (GFAP immunostain, original magnifi cation ×100). E) Penetrating artery with abundant 
CD3+ T-cells in the perivascular space and adjacent brain parenchyma (CD3+ immunostain, original magnifi cation ×25). F) CD3+ T-cells as 
part of microglial nodules (CD3+ immunostain, original magnifi cation ×100). G) White matter in the internal capsule showing myelin clumps 
(arrowheads) and vacuolation (arrow) (LFB/PAS, original magnifi cation ×100). H) Loss of axons in the internal capsule (Bielschowsky nerve 
fi ber silver stain, original magnifi cation ×100). I) Internal capsule with marked microgliosis (CD68+ immunostain, original magnifi cation 
×40). J) Microcalcifi cations (arrow) in the globus pallidus (LFB/PAS, original magnifi cation ×100). All paraffi n sections were counterstained 
with hematoxylin.
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No viral RNA was found in postmortem kidney, liver, or 
spleen specimens.
Commercial antibodies to human astroviruses did not 
stain infected brain (data not shown). Therefore, poly-
clonal antibodies were generated by injecting rabbits with 
recombinant capsid protein of HAstV-PS. Indirect double-
immunofl uorescence staining of postmortem tissue sec-
tions demonstrated capsid protein in hypertropic astrocytes 
throughout the subcortical white matter and cortex (Figure 
4, panel A). Astrocytes had swollen cell bodies and showed 
intense immunostaining of the glial fi brillary acidic pro-
tein. Indirect immunohistochemical staining of a frontal 
cortex brain biopsy specimen demonstrated intracytoplas-
mic capsid protein in only 1 cell; morphologic appearance 
was consistent with that of a neuron (Figure 4, panel B). 
No evidence of infection was found in oligodendrocytes or 
macrophages.
Discussion
The astrovirus identifi ed in the central nervous sys-
tem (CNS) of an immunocompromised patient with XLA 
and encephalitis was discovered through unbiased high-
throughput pyrosequencing after conventional methods 
failed to identify an infectious agent. The astrovirus infec-
tion was confi rmed by specifi c PCR and antigen detection. 
To prove causation according to the Koch postulates, the 
infectious agent must be propagated and must reproduce 
disease in a previously unexposed host (13); to prove cau-
sation according to Rivers, a specifi c humoral immune re-
sponse to infection must be found (14). Because we have 
not been able to grow the astrovirus in culture and because 
persons with XLA do not generate specifi c antibodies, these 
criteria have not been met. Nonetheless, the neuropatho-
logic fi ndings consistent with viral encephalitis in conjunc-
tion with the high viral load found in the CNS suggest a 
causative association between HAstV-PS and disease. The 
most prominent histologic lesions in the brain consisted of 
severe neuronal degeneration, hypertrophic astrocytes, and 
infi ltration by T-lymphocytes and macrophages. Although 
we cannot exclude prominent neuronal infection earlier in 
the course of infection, immunohistochemical and immu-
nofl uorescence studies localized astroviral protein mainly 
in astrocytes.
Astrocytes are essential to neuronal function and vi-
ability (15); they are critical for maintenance of the blood–
brain barrier; they provide axon guidance during develop-
ment and structural support to neural elements; and they 
are involved in CNS homeostasis as regulators of extracel-
lular glutamate, ionic environment, and pH (16). Astrocyte 
dysfunction is implicated in the pathogenesis of acute and 
chronic CNS disorders (16,17). Recent data indicate that 
infected astrocytes play a role in the pathogenesis of HIV-
associated dementia, a neurodegenerative disorder (18). 
The essential features of this disorder are cognitive and mo-
tor impairment, speech problems, and behavioral changes. 
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Figure 2. Schematic genome organization of human astrovirus 
Puget Sound (HAstV-PS). Arrows represent the 3 open reading 
frames of the 6,584-nt single-strand, positive-sense genome. Bars 
above the schematic indicate the 12 contiguous fragments (contigs 
A–L) generated through unbiased high-throughput sequencing. 
PCR primers for amplifi cation across sequence gaps were designed 
based on the unbiased high-throughput sequencing data, and the 
draft genome was resequenced by overlapping PCR products that 
covered the entire genome except for terminal sequences. Genomic 
termini were characterized with 5′ and 3′ rapid amplifi cation of cDNA 
ends kits (Invitrogen, Carlsbad, CA, USA). Arrowheads indicate 
primer locations. PRO, protease; POL, polymerase; CA, capsid; 
(A)n, poly-A tail.
Table 5. Genomic  location of HAstV-PS contigs identified by 454 pyrosequencing and their relationship to known astroviruses* 
Contiguous
fragment Genome position in HAstV-PS Highest amino acid identity, % GenBank accession no.† 
Astrovirus
species
A 238–504 52 NP_795334 Mink
B 1765–1839 64 NP_795334 Mink
C 2012–2184 67 NP_795334 Mink
D 2308–2466 42 NP_059945 Ovine
E 2763–2945 48 AAO32082 Mink
F 3360–3728 65 NP_059945 Ovine
G 4558–4679 65 NP_795336 Mink
H 4558–5140 70 NP_059946 Ovine
I 4708–4944 72 NP_795336 Mink
J 4801–5110 72 NP_059946 Ovine
K 4819–4929 76 NP_059946 Ovine
L 5104–5331 70 NP_059946 Ovine
* HAstV-PS, human astrovirus Puget Sound. 
†Accession number for BLASTX (www.ncbi.nlm.nih.gov/blast/Blast.cgi) match with highest amino acid identity (GenBank database December 2007). 
Astrovirus Encephalitis
Similar to fi ndings for the patient described here, HIV-as-
sociated dementia is characterized by infi ltration of mac-
rophages into the CNS, gliosis, pallor of myelin sheaths, 
and loss of neurons (19).
Astroviruses have not previously been associated with 
CNS disease. They are nonenveloped, single-stranded 
RNA viruses, are typically transmitted by the fecal–oral 
route, and cause mild gastrointestinal disease. Antibodies 
to human astrovirus-1 have been found in >90% of the hu-
man population (20). Immunocompromised persons are 
prone to astrovirus infections of the gastrointestinal tract 
(21). Postmortem analysis of the gastrointestinal tract of 
the patient described in this article found no evidence of 
astrovirus infection (data not shown); however, we cannot 
exclude the possibility of a gastrointestinal infection that 
cleared before the patient died.
The fact that the patient had XLA may explain dis-
semination of the astrovirus to the CNS. XLA is a primary 
immunodefi ciency disorder caused by mutations in the Btk 
gene, which results in absence of B lymphocytes and serum 
immunoglobulins (22). Several recent reports demonstrate 
that Btk is required for Toll-like receptor 8–mediated pro-
duction of interleukin-6 and production of tumor necrosis 
factor-α by peripheral blood mononuclear cell–derived 
dendritic cells (23,24). Hence, Btk defi ciency may impair 
innate immune responses after a person is infected with 
single-stranded RNA viruses known to cause fatal CNS in-
fection in those with XLA (25,26), such as enteroviruses, 
and now, potentially, astroviruses.
The source of infection for the patient described here 
remains unknown. Exposure to mink was a potential source, 
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Table 6. Primers used in cloning and sequencing the human 
astrovirus Puget Sound genome 

























































*Primer pairs designed for amplification between ultra–high-throughput 
sequencing contiguous fragments (Figure 2); primer pairs without asterisk 
were applied for resequencing of the draft genome. 
Figure 3. Phylogenetic analysis of full-length capsid protein 
sequences showing the relationship between human astrovirus 
Puget Sound (HAstV-PS) identifi ed in brain of 15-year-old boy 
with X-linked agammaglobulinemia and encephalitis and other 
astroviruses. GenBank accession numbers in parentheses: MLB1 
(FJ22245), VA1 (FJ973620), HAstV-1 (AB000295), HAstV-2 
(L06802), HAstV-3 (DQ630763), HAstV-4 (AB025803), HAstV-5 
(U15136), HAstV-6 (Z46658), HAstV-7 (Y08632), HAstV-8 (Z66541), 
MAstV (AY179509), OAstV (NC_002469), BatAstV (FJ571074), 
FAstV (AF056197), ChAstV (EU650331), PAstV (Y15938), ANV 1 
(AB033998), ANV 2 (AB046864), TAstV 1 (Y15936), and TAstV 2 
(AY769615). Bayesian posterior probability values >75% are shown 
at respective nodes. FAstV, feline astrovirus;  ChAstV, cheetah 
astrovirus; PAstV, porcine astrovirus; OAstV, ovine astrovirus; 
MAstV, mink astrovirus; ANV, avian nephritis virus; TAstV, turkey 
astrovirus. Scale bar indicates number of amino acid substitutions 
per site.
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suggested by the phylogenetic relationship of HAstV-PS to 
mink astroviruses and the proximity of the patient’s res-
idence to a mink farm. Another possible source was the 
patient’s monthly treatment with intravenous immunoglob-
ulin. Several reports describe progressive neurodegenera-
tion of unknown cause in immunosuppressed patients who 
received long-term intravenous immunoglobulin therapy 
(26,27). Some of these patients had neuropathologic fi nd-
ings similar to those reported here (26,27). Intravenous im-
munoglobulin preparations from 5 companies (Vivaglobin 
[CSL Behring GmbH, Marburg, Germany], Carimune 
[CSL Behring GmbH], Gammagard [Baxter, Westlake 
Village, CA, USA], Gamimune N [Bayer Healthcare Phar-
maceuticals, West Haven, CT, USA], Flebogamma [Insti-
tuto Grifols, S.A. Barcelona, Spain]) were negative for the 
newly identifi ed astrovirus, according to ELISA and PCR 
(data not shown).
The recent fi nding of an astrovirus closely related to 
HAstV-PS in fecal samples from children from Virginia 
with acute gastroenteritis (28) suggests that these novel vi-
ruses are circulating widely in humans across the United 
States. They should be considered in the differential diag-
nosis of encephalitis, particularly for immunosuppressed 
patients.
Despite extensive microbiologic investigation, the 
causes of up to 75% of encephalitis cases remain elusive. 
These undiagnosed cases pose a challenge for clinical med-
icine and public health and underscore the need to invest in 
developing new methods for investigating these debilitat-
ing, frequently fatal, disorders. To address the challenge 
of unexplained encephalitis, public health practitioners and 
diagnosticians need a more comprehensive armamentarium 
and methods that would enable them to discover new and 
unexpected pathogens associated with encephalitis. Our 
fi ndings emphasize the value of unbiased pyrosequencing 
as a powerful tool for diagnosing the cause of encephalitis 
and the need to consider astroviruses as CNS pathogens, 
particularly in immunosuppressed persons. Early recog-
nition of the causative agent of unexplained encephalitis 
cases will enable specifi c interventions that reduce illness 
and death and facilitate the recognition of outbreaks that 
threaten public health.
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Figure 4. Immunofl uorescence and immunohistochemical analyses 
with human astrovirus Puget Sound capsid antibodies. A)  Indirect 
double immunofl uorescence–stained, formalin-fi xed, paraffi n-
embedded tissue sections from 15-year-old boy with X-linked 
agammaglobulinemia and astrovirus encephalitis and a control with 
astrogliosis not caused by astrovirus infection. The sections were 
stained for the astrocyte marker glial fi brillary acidic protein (GFAP, 
green) and for viral capsid protein (rabbit serum 1:1,000, red). Viral 
capsid protein is present in hypertropic astrocytes throughout the 
subcortical white matter and cortex; astrocytes have swollen cell 
bodies with intense GFAP immunostaining. Blue signal (DAPI) 
indicates nuclear counterstaining. Original magnifi cation ×100. B) 
Immunohistochemical localization of viral antigen in a frontal cortex 
biopsy specimen. Immunoalkaline phosphatase stain with viral 
capsid antibodies (rabbit serum 1:1,000) and naphthol-fast red with 
hematoxylin counterstain. Original magnifi cation ×158.
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